Si-Yi Xie

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial

Sai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang et al. · The Lancet Oncology · 2024 · 54 citations · Full text

Medicine, Oncology, Oncologic Surgery +11

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial

Yuan Li, Guo-Dong Jia, Xiaofei Lv et al. · Nature Communications · 2023 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Li‐Ting Liu, Huai Liu, Ying Huang et al. · The Lancet Oncology · 2023 · 39 citations

Medicine, Oncology, Radiation Oncology +16

Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016

Si-Yi Xie, Dong–Hua Luo, Li‐Ting Liu et al. · Radiotherapy and Oncology · 2021 · 18 citations

Medicine, Oncology, Cancer Epidemiology +8

Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?

Jing-Rong Mao, Kai‐Qi Lan, Sai-Lan Liu et al. · Radiotherapy and Oncology · 2022 · 17 citations

Medicine, Oncology, Diagnostic Assessment +5